Do Ozempic and Similar Weight Loss Drugs Work for Everyone? New Study Has Answers
Summary
A comprehensive review of clinical trials reveals that popular GLP-1 receptor agonist drugs deliver consistent weight-loss results across diverse demographics. These medications have transitioned from niche diabetes treatments to mainstream solutions for obesity management, highlighting their growing significance in healthcare.
Key Insights
Do Ozempic and similar GLP-1 drugs produce the same weight loss results across different demographics?
Clinical trials indicate consistent weight loss efficacy across diverse groups, though averages show women losing about 11% of starting weight compared to 7% for men; results vary individually with some losing more and others less or even gaining weight.
Sources:
[1]
Does weight loss continue indefinitely with Ozempic and similar drugs, or does it plateau?
Weight loss typically plateaus after about one year of treatment despite continued use, with long-term studies showing an average total loss of around 9-10% over placebo after four years, though some achieve more significant reductions.
Sources:
[1]